Comparison Overview

Eli Lilly and Company

VS

Parexel

Eli Lilly and Company

Lilly Corporate Center, Indianapolis, Indiana, US, 46285
Last Update: 2025-12-17
Between 800 and 849

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 49,376
Subsidiaries: 16
12-month incidents
0
Known data breaches
0
Attack type number
0

Parexel

541 Church at North Hills St, 1000, Raleigh, North Carolina, US, 27609
Last Update: 2025-12-17
Between 750 and 799

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 20,504
Subsidiaries: 0
12-month incidents
1
Known data breaches
0
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/eli-lilly-and-company.jpeg
Eli Lilly and Company
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/parexel.jpeg
Parexel
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Eli Lilly and Company
100%
Compliance Rate
0/4 Standards Verified
Parexel
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Eli Lilly and Company in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

Parexel has 9.89% more incidents than the average of same-industry companies with at least one recorded incident.

Incident History — Eli Lilly and Company (X = Date, Y = Severity)

Eli Lilly and Company cyber incidents detection timeline including parent company and subsidiaries

Incident History — Parexel (X = Date, Y = Severity)

Parexel cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/eli-lilly-and-company.jpeg
Eli Lilly and Company
Incidents

No Incident

https://images.rankiteo.com/companyimages/parexel.jpeg
Parexel
Incidents

Date Detected: 10/2025
Type:Vulnerability
Blog: Blog

FAQ

Eli Lilly and Company company demonstrates a stronger AI Cybersecurity Score compared to Parexel company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Parexel company has historically faced a number of disclosed cyber incidents, whereas Eli Lilly and Company company has not reported any.

In the current year, Parexel company has reported more cyber incidents than Eli Lilly and Company company.

Neither Parexel company nor Eli Lilly and Company company has reported experiencing a ransomware attack publicly.

Neither Parexel company nor Eli Lilly and Company company has reported experiencing a data breach publicly.

Neither Parexel company nor Eli Lilly and Company company has reported experiencing targeted cyberattacks publicly.

Parexel company has disclosed at least one vulnerability, while Eli Lilly and Company company has not reported such incidents publicly.

Neither Eli Lilly and Company nor Parexel holds any compliance certifications.

Neither company holds any compliance certifications.

Eli Lilly and Company company has more subsidiaries worldwide compared to Parexel company.

Eli Lilly and Company company employs more people globally than Parexel company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Eli Lilly and Company nor Parexel holds SOC 2 Type 1 certification.

Neither Eli Lilly and Company nor Parexel holds SOC 2 Type 2 certification.

Neither Eli Lilly and Company nor Parexel holds ISO 27001 certification.

Neither Eli Lilly and Company nor Parexel holds PCI DSS certification.

Neither Eli Lilly and Company nor Parexel holds HIPAA certification.

Neither Eli Lilly and Company nor Parexel holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.

Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.

Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description

Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.

Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X